Navigation Links
BMI Surplus Announces Sale of Thermal Vacuum Space Simulation Chamber

Hanover, MA (PRWEB) March 27, 2013

BMI Surplus, Inc., a seller of hard-to-find and unique used scientific equipment, has a used Thermal Vacuum Space Simulation Chamber. This unit was dismantled from a working class 1000 clean room lab and sent to an indoor storage facility.

The Thermal Vacuum Space Simulation Chamber was built by Chicago Bridge and Iron Works, is constructed of 304L stainless steel. The size is mammoth, spanning almost 27 feet, more than 15 feet wide and nearly 14 feet high. Included with the chamber is the thermal shroud, six vibration isolators, roughing pumps with LN2 cooled cold trap, two cryopumps, and turbomolecular pump system; plus, the GN2 Thermal system including the blower, heater and exchanger.

Robert Brams, President of BMI Surplus and owner of the Thermal Vacuum Space Simulation Chamber states, “I consider this Chamber an asset and am highly motivated to sell this Vacuum Chamber in 2013. We are in a good position to make a great deal with the right company, research facility, or university that has the need for this valuable Chamber.”

The chamber was designed to test material under the conditions of earth’s orbit or deep space simulation. Applications include satellite and solar panels but would also be useful for large-scale vacuum coating processes. Original drawings and system manuals are included.

“To have a new chamber of this size built would take at least a year in production. So, the advantage to buying this used Vacuum Chamber is time,” continued Brams.

The employees at BMI Surplus have joked about using the Space Simulation Vacuum Chamber as a survival shelter as it is large enough to house a small family as a recent blog post states. But, for potential vacuum chamber customers this is no joke, saving a year in production time means saving money.

For more information:
Visit: The Thermal Vacuum Space Simulation Chamber at BMI Surplus
Call 781-871-8868

About BMI Surplus, Inc.
Founded by Robert Brams, BMI Surplus Inc. has been a premier seller of surplus and used scientific equipment for over 26 years with exciting growth. In recent years, BMI Surplus has invested in state of the art inventory software, launched a new e-commerce website with over 30,000 ready-to-ship items in stock, partnered with more specialists to test equipment and now, the final frontier…social media. BMI Surplus Inc. has certainly earned its reputation in selling quality used scientific equipment, optical tables and breadboards, microscopes, microwave, computer components, optical components, and machinery. We also carry a large assortment of vacuum equipment, semi-conductor processing equipment, laboratory instrumentation, microscopes, test equipment, avionics instruments, process equipment, lasers and much more.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BMI Surplus Launches Interactive Blog with Scientific Equipment Contests
2. XBiotech Announces Incorporation Of Its Wholly Owned Subsidiary XBiotech Japan KK
3. National Brain Tumor Society Announces Launch of Defeat GBM Research Collaborative
4. Regenerative Medicine Company, Eqalix, Announces Grant from Nanotechnology Institute in Philadelphia, Pennsylvania
5. Probiotics Are in More Than Just Yogurt: Probiotic Action Announces 5 New Items Containing the Healthy Bacteria
6. Synedgen Announces Issuance of Patent to Optimize Animal Health
7. Piramal Imaging Announces the Acceptance for Review of [18F] florbetaben by the FDA and EMA for the Visual Detection of beta-amyloid in Alzheimers Disease
8. Probiotic Action Announces Probiotics Pending Listing on EU Foods
9. Butamax Announces Immediate Appeal of Court Decisions on Claim Construction and Summary Judgment
10. Neogen Corporation Announces 3rd Quarter Results Conference Call
11. Medifirst Solutions, Inc. Announces Further Update To Shareholders
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology:
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
Breaking Biology News(10 mins):